Our findings show that combinatorial expression of immune modulators is feasible using AAV, and that additional work is required to identify factors that can more strongly modulate inflammatory processes in the SOD1-G93A model of ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.